We are live on
!
Find out more
FNA
First National Advisers Portfolio holdings
AUM
$712M
1-Year Est. Return
30.64%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+30.64%
3 Year Est. Return
+87.89%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$88.2M
AUM Growth
+$10.1M
(+13%)
Cap. Flow
+$4.72M
Cap. Flow
% of AUM
5.35%
Top 10 Holdings %
Top 10 Hldgs %
27.76%
Holding
114
New
6
Increased
84
Reduced
17
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$801K |
| 2 |
InMode
INMD
|
+$412K |
| 3 |
Abbott
ABT
|
+$402K |
| 4 |
Robert Half
RHI
|
+$266K |
| 5 |
Comcast
CMCSA
|
+$266K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$749K |
| 2 |
Corpay
CPAY
|
+$635K |
| 3 |
LHCG
LHC Group LLC
LHCG
|
+$622K |
| 4 |
AMN Healthcare
AMN
|
+$407K |
| 5 |
KeyCorp
KEY
|
+$212K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.82% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 12.71% |
| 4 | Industrials | 10.23% |
| 5 | Consumer Discretionary | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lamb Weston
LW
$7.22B
| $991K | 1.12% |
9,479
+512
| +6% | +$50.6K |
|
27
Linde
LIN
$221B
| $976K | 1.11% |
2,745
+164
| +6% | +$54.9K |
|
28
Cintas
CTAS
$81.9B
| $966K | 1.1% |
8,352
+2,176
| +35% | +$240K |
|
29
CME Group
CME
$96.3B
| $932K | 1.06% |
4,865
+426
| +10% | +$77K |
|
|
ATVI
30
DELISTED
Activision Blizzard
ATVI
| $932K | 1.06% |
10,888
+868
| +9% | +$67.4K |
|
31
Meta Platforms (Facebook)
META
$1.42T
| $928K | 1.05% |
4,380
+1,401
| +47% | +$239K |
|
32
Atmos Energy
ATO
$28.8B
| $927K | 1.05% |
8,248
+1,269
| +18% | +$144K |
|
33
Qualcomm
QCOM
$155B
| $923K | 1.05% |
7,233
-70
| -1% | -$8.7K |
|
34
Zoetis
ZTS
$32.4B
| $904K | 1.03% |
5,433
+160
| +3% | +$26.2K |
|
35
Brown & Brown
BRO
$23.6B
| $900K | 1.02% |
15,671
+2,440
| +18% | +$140K |
|
|
FISV
36
Fiserv Inc
FISV
$28.8B
| $869K | 0.99% |
7,689
+342
| +5% | +$37.6K |
|
37
Church & Dwight Co
CHD
$23.4B
| $861K | 0.98% |
9,738
+233
| +2% | +$19.4K |
|
38
Home Depot
HD
$331B
| $859K | 0.97% |
2,910
+90
| +3% | +$27.6K |
|
39
Adobe
ADBE
$99.5B
| $837K | 0.95% |
2,172
-29
| -1% | -$10.3K |
|
40
CSX Corp
CSX
$93.4B
| $837K | 0.95% |
27,962
+852
| +3% | +$26.2K |
|
41
Lantheus
LNTH
$6.49B
| $817K | 0.93% |
9,896
+708
| +8% | +$45.7K |
|
|
42
Jazz Pharmaceuticals
JAZZ
$15.9B
| $793K | 0.9% |
+5,416
| New | +$801K |
|
43
Constellation Brands
STZ
$22.2B
| $787K | 0.89% |
3,482
+73
| +2% | +$16.2K |
|
44
Nike
NKE
$61.9B
| $772K | 0.88% |
6,292
+772
| +14% | +$94.9K |
|
45
Phillips 66
PSX
$84.9B
| $738K | 0.84% |
7,279
+1,937
| +36% | +$197K |
|
46
AT&T
T
$159B
| $702K | 0.8% |
36,460
| – | – |
|
47
EOG Resources
EOG
$79.2B
| $681K | 0.77% |
5,941
+288
| +5% | +$34.9K |
|
|
HZNP
48
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $666K | 0.76% |
6,098
-6,772
| -53% | -$749K |
|
49
MasTec
MTZ
$21.1B
| $659K | 0.75% |
6,981
-34
| -0.5% | -$3.23K |
|
50
Paycom
PAYC
$7.64B
| $654K | 0.74% |
2,152
+545
| +34% | +$164K |
|
Similar funds
PCS
AMPWP
DCM
TLP
SSP
DCM
IWP
DIA
First National Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, First National Advisers held 114 positions worth $88.2M, up 13% from $78.1M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
First National Advisers deployed $4.72M of net new capital in Q1 2023, opening 6 new positions and adding to 84 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 5,416 shares worth $793K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $749K trimmed.
- First National Advisers's largest Q1 2023 buy was Jazz Pharmaceuticals: 5,416 shares worth $793K.
- First National Advisers added most to Abbott in Q1 2023, an estimated $402K increase.
- First National Advisers's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $749K.
- First National Advisers fully exited Corpay in Q1 2023, selling an estimated $635K.
- First National Advisers's ten largest holdings make up 28% of its $88.2M portfolio in Q1 2023.
- First National Advisers opened 6 new positions and closed 4 in Q1 2023.
- First National Advisers's portfolio value rose 13% quarter-over-quarter to $88.2M.
Based on First National Advisers's 13F filing for Q1 2023, filed 10 May 2023.